The effect of glucocorticoids on bone mass in rheumatoid arthritis patients. Influence of menopausal state
The DOI matches its Crossref record.
Abstract
We studied 97 patients with definite or classic rheumatoid arthritis (RA). Fifty‐four patients (19 premenopausal women, 25 postmenopausal women, and 10 men) had been treated with low‐dose glucocorticoids for at least 12 months (mean dose <10 mg/day). The remaining 43 patients (15 premenopausal women, 17 postmenopausal women, and 11 men) had been treated with penicillamine, and served as a patient control group. The distal forearm bone mineral content (BMC) was measured in all patients by single photon absorptiometry using 125 I, and the total body bone mineral (TBBM) was measured in 61 patients by dual photon absorptiometry using 153 Gd. Compared with normal controls, both treatment groups had significantly decreased BMC and TBBM (0.01 < P < 0.001). When the patients were stratified according to pre‐ and postmenopausal state, we found significantly lower BMC and TBBM values in the premenopausal glucocorticoid‐treated women than in penicillamine‐treated women. However, no differences in BMC and TBBM values were found in the corresponding postmenopausal groups. In the premenopausal women treated with glucocorticoids, the duration of treatment and cumulative dose correlated with BMC. No such correlations were found in the postmenopausal women. We conclude that 1) RA is associated with loss of bone mass, 2) systemic glucocorticoid treatment further aggravates the bone loss, 3) in postmenopausal RA patients, the bone loss resulting from menopause and from the disease itself is not accelerated by low‐dose glucocorticoids, and 4) in premenopausal RA patients, however, the bone mass is significantly affected by glucocorticoid treatment. We therefore suggest that these factors be considered when prescribing glucocorticoids, in order to minimize the bone loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management
Lukert, B. P., & Raisz, L. G. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-352 · Cited by 1,066
Saag, K. G., Koehnke, R., Caldwell, J. R., Brasington, R., Burmeister, L. F., Zimmerman, B., Kohler, J. A., & Furst, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90131-7 · Cited by 540
Bone loss in response to long-term glucocorticoid therapy
LoCascio, V., Bonucci, E., Imbimbo, B., Ballanti, P., Adami, S., Milani, S., Tartarotti, D., & DellaRocca, C. (1990) · Bone and Mineral · doi:10.1016/0169-6009(91)90139-q · Cited by 384
Peel, N. F., Moore, D. J., Barrington, N. A., Bax, D. E., & Eastell, R. (1995) · Annals of the Rheumatic Diseases · doi:10.1136/ard.54.10.801 · Cited by 379
PREDICTION OF RAPID BONE LOSS IN POSTMENOPAUSAL WOMEN
Christiansen, C., Riis, B. J., & Rødbro, P. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91671-0 · Cited by 364
Self-citationOral glucocorticoid use is associated with an increased risk of fracture
Steinbuch, M., Youket, T. E., & Cohen, S. (2004) · Osteoporosis International · doi:10.1007/s00198-003-1548-3 · Cited by 277
Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice.
Schett, G., Redlich, K., Hayer, S., Zwerina, J., Bolon, B., Dunstan, C., Görtz, B., Schulz, A., Bergmeister, H., Kollias, G., et al. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11150 · Cited by 150
Johansson, A. G., Baylink, D. J., af Ekenstam, E., Lindh, E., Mohan, S., & Ljunghall, S. (1994) · Bone and Mineral · doi:10.1016/s0169-6009(08)80128-6 · Cited by 45
ALS, O. S., RIIS, B. J., GOTFREDSEN, A., CHRISTIANSEN, C., & DEFTOS, L. J. (1986) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1986.tb03300.x · Cited by 23
Self-citation
Metadata
- Authors
- Als, O. S., Gotfredsen, A., & Christiansen, C.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1985-04
- Volume
- 28
- Issue
- 4
- Pages
- 369-375
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1975207277
- Cited by
- 105
- References
- 0
- FWCI
- 12.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.